DCGI supports Restricted Use of Anti-viral Drug Favipiravir for Coronavirus Patients - Microbioz India
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials